Clinical Trial Update: Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating acetyl-L-carnitine in hepatic encephalopathy reports reductions in perceived work stress and improvements in work ability and work perf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: University of Catania | Conditions: Work Stress, Work Ability | Phase 3 | Status: COMPLETED